Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia-Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study.

Rama Al Hamed,Maud Ngoya,Jacques-Emmanuel Galimard,Henrik Sengeloev,Tobias Gedde-Dahl,Aleksandr Kulagin,Uwe Platzbecker,Ibrahim Yakoub-Agha,Jenny L Byrne,Thomas Valerius,Gerard Socie,Nicolaus Kröger,Didier Blaise,Ali Bazarbachi,Jaime Sanz,Fabio Ciceri,Arnon Nagler,Mohamad Mohty

Cancer（2023）

引用 0|浏览15

暂无评分

摘要

Even in the absence of an MSD, outcomes of allo-HCT in CR2 for AML have significantly improved over time, with most favorable outcomes achieved with a MUD.

查看译文

关键词

acute myeloid leukemia—improved,transplantation,second complete remission

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要